Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Regulation of cell cycle checkpoint kinase WEE1 by miR-195 in malignant melanoma

Oncogene volume 32, pages 3175–3183 (2013)Cite this article

Subjects

Abstract

WEE1 kinase has been described as a major gate keeper at the G2 cell cycle checkpoint and to be involved in tumour progression in different malignant tumours. Here we analysed the expression levels of WEE1 in a series of melanoma patient samples and melanoma cell lines using immunoblotting, quantitative real-time PCR and immunohistochemistry. WEE1 expression was significantly downregulated in patient samples of metastatic origin as compared with primary melanomas and in melanoma cell lines of high aggressiveness as compared with cell lines of low aggressiveness. Moreover, there was an inverse correlation between the expression of WEE1 and WEE1-targeting microRNA miR-195. Further analyses showed that transfection of melanoma cell lines with miR-195 indeed reduced WEE1 mRNA and protein expression in these cells. Reporter gene analysis confirmed direct targeting of the WEE1 3′ untranslated region (3′UTR) by miR-195. Overexpression of miR-195 in SK-Mel-28 melanoma cells was accompanied by WEE1 reduction and significantly reduced stress-induced G2-M cell cycle arrest, which could be restored by stable overexpression of WEE1. Moreover, miR-195 overexpression and WEE1 knockdown, respectively, increased melanoma cell proliferation. miR-195 overexpression also enhanced migration and invasiveness of melanoma cells. Taken together, the present study shows that WEE1 expression in malignant melanoma is directly regulated by miR-195. miR-195-mediated downregulation of WEE1 in metastatic lesions may help to overcome cell cycle arrest under stress conditions in the local tissue microenvironment to allow unrestricted growth of tumour cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. McGowan CH, Russell P . Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15. EMBO J 1993; 12: 75–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. O'Connell MJ, Raleigh JM, Verkade HM, Nurse P . Chk1 is a wee1 kinase in the G2 DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation. EMBO J 1997; 16: 545–554.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Mir SE, De Witt Hamer PC, Krawczyk PM, Balaj L, Claes A, Niers JM et al. In silico analysis of kinase expression identifies WEE1 as a gatekeeper against mitotic catastrophe in glioblastoma. Cancer Cell 2010; 18: 244–257.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Talantov D, Mazumder A, Yu JX, Briggs T, Jiang Y, Backus J et al. Novel genes associated with malignant melanoma but not benign melanocytic lesions. Clin Cancer Res 2005; 11: 7234–7242.

    Article  CAS  PubMed  Google Scholar 

  5. Hashimoto O, Ueno T, Kimura R, Ohtsubo M, Nakamura T, Koga H et al. Inhibition of proteasome-dependent degradation of Wee1 in G2-arrested Hep3B cells by TGF beta 1. Mol Carcinog 2003; 36: 171–182.

    Article  CAS  PubMed  Google Scholar 

  6. Wang Y, Li J, Booher RN, Kraker A, Lawrence T, Leopold WR et al. Radiosensitization of p53 mutant cells by PD0166285, a novel G(2) checkpoint abrogator. Cancer Res 2001; 61: 8211–8217.

    CAS  PubMed  Google Scholar 

  7. Yoshida T, Tanaka S, Mogi A, Shitara Y, Kuwano H . The clinical significance of Cyclin B1 and Wee1 expression in non-small-cell lung cancer. Ann Oncol 2004; 15: 252–256.

    Article  CAS  PubMed  Google Scholar 

  8. Bartel DP . MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215–233.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Esquela-Kerscher A, Slack FJ . Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259–269.

    Article  CAS  PubMed  Google Scholar 

  10. Rai D, Kim SW, McKeller MR, Dahia PL, Aguiar RC . Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis. Proc Natl Acad Sci USA 2010; 107: 3111–3116.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Ma L, Teruya-Feldstein J, Weinberg RA . Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007; 449: 682–688.

    Article  CAS  PubMed  Google Scholar 

  12. Ma L, Reinhardt F, Pan E, Soutschek J, Bhat B, Marcusson EG et al. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol 2010; 28: 341–347.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Medina PP, Nolde M, Slack FJ . OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 2010; 467: 86–90.

    Article  CAS  PubMed  Google Scholar 

  14. Swarbrick A, Woods SL, Shaw A, Balakrishnan A, Phua Y, Nguyen A et al. miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma. Nat Med 2010; 16: 1134–1140.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Miller AJ, Mihm MC . Melanoma. N Engl J Med 2006; 355: 51–65.

    Article  CAS  PubMed  Google Scholar 

  16. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ . Efficient tumour formation by single human melanoma cells. Nature 2008; 456: 593–598.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Felicetti F, Errico MC, Bottero L, Segnalini P, Stoppacciaro A, Biffoni M et al. The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. Cancer Res 2008; 68: 2745–2754.

    Article  CAS  PubMed  Google Scholar 

  18. Muller DW, Bosserhoff AK . Integrin beta 3 expression is regulated by let-7a miRNA in malignant melanoma. Oncogene 2008; 27: 6698–6706.

    Article  CAS  PubMed  Google Scholar 

  19. Philippidou D, Schmitt M, Moser D, Margue C, Nazarov PV, Muller A et al. Signatures of microRNAs and selected microRNA target genes in human melanoma. Cancer Res 2010; 70: 4163–4173.

    Article  CAS  PubMed  Google Scholar 

  20. Qi J, Yu JY, Shcherbata HR, Mathieu J, Wang AJ, Seal S et al. microRNAs regulate human embryonic stem cell division. Cell Cycle 2009; 8: 3729–3741.

    Article  CAS  PubMed  Google Scholar 

  21. Liu L, Chen L, Xu Y, Li R, Du X . microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells. Biochem Biophys Res Commun 2010; 400: 236–240.

    Article  CAS  PubMed  Google Scholar 

  22. Ujifuku K, Mitsutake N, Takakura S, Matsuse M, Saenko V, Suzuki K et al. miR-195, miR-455-3p and miR-10a(*) are implicated in acquired temozolomide resistance in glioblastoma multiforme cells. Cancer Lett 2010; 296: 241–248.

    Article  CAS  PubMed  Google Scholar 

  23. Levati L, Alvino E, Pagani E, Arcelli D, Caporaso P, Bondanza S et al. Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155. Int J Oncol 2009; 35: 393–400.

    CAS  PubMed  Google Scholar 

  24. Jewell R, Conway C, Mitra A, Randerson-Moor J, Lobo S, Nsengimana J et al. Patterns of expression of DNA repair genes and relapse from melanoma. Clin Cancer Res 2010; 16: 5211–5221.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Bueno MJ, Malumbres M . MicroRNAs and the cell cycle. Biochim Biophys Acta 2011; 1812: 592–601.

    Article  CAS  PubMed  Google Scholar 

  26. Li D, Zhao Y, Liu C, Chen X, Qi Y, Jiang Y et al. Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer. Clin Cancer Res 2011; 17: 1722–1730.

    Article  CAS  PubMed  Google Scholar 

  27. Xu T, Zhu Y, Xiong Y, Ge YY, Yun JP, Zhuang SM . MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. Hepatology 2009; 50: 113–121.

    Article  CAS  PubMed  Google Scholar 

  28. Meltzer PS . Cancer genomics: small RNAs with big impacts. Nature 2005; 435: 745–746.

    Article  CAS  PubMed  Google Scholar 

  29. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S et al. A microRNA polycistron as a potential human oncogene. Nature 2005; 435: 828–833.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT . c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005; 435: 839–843.

    Article  CAS  PubMed  Google Scholar 

  31. Zhang L, Huang J, Yang N, Greshock J, Megraw MS, Giannakakis A et al. microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA 2006; 103: 9136–9141.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Yu Z, Wang C, Wang M, Li Z, Casimiro MC, Liu M et al. A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J Cell Biol 2008; 182: 509–517.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Lee J, Kumagai A, Dunphy WG . Positive regulation of Wee1 by Chk1 and 14-3-3 proteins. Mol Biol Cell 2001; 12: 551–563.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. van Vugt MA, Bras A, Medema RH . Polo-like kinase-1 controls recovery from a G2 DNA damage-induced arrest in mammalian cells. Mol Cell 2004; 15: 799–811.

    Article  CAS  PubMed  Google Scholar 

  35. Wang F, Zhu Y, Huang Y, McAvoy S, Johnson WB, Cheung TH et al. Transcriptional repression of WEE1 by Kruppel-like factor 2 is involved in DNA damage-induced apoptosis. Oncogene 2005; 24: 3875–3885.

    Article  CAS  PubMed  Google Scholar 

  36. Hirai H, Iwasawa Y, Okada M, Arai T, Nishibata T, Kobayashi M et al. Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents. Mol Cancer Ther 2009; 8: 2992–3000.

    Article  CAS  PubMed  Google Scholar 

  37. Hirai H, Arai T, Okada M, Nishibata T, Kobayashi M, Sakai N et al. MK-1775, a small molecule Wee1 inhibitor, enhances anti-tumor efficacy of various DNA-damaging agents, including 5-fluorouracil. Cancer Biol Ther 2010; 9: 514–522.

    Article  CAS  PubMed  Google Scholar 

  38. Beck H, Nahse V, Larsen MS, Groth P, Clancy T, Lees M et al. Regulators of cyclin-dependent kinases are crucial for maintaining genome integrity in S phase. J Cell Biol 2010; 188: 629–638.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Hanahan D, Weinberg RA . Hallmarks of cancer: the next generation. Cell 2011; 144: 646–674.

    Article  CAS  PubMed  Google Scholar 

  40. Schultz J, Lorenz P, Gross G, Ibrahim S, Kunz M . MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. Cell Res 2008; 18: 549–557.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank T Magin, Translational Centre for Regenerative Medicine (TRM), Division of Cell and Developmental Biology, University of Leipzig, for helpful advice and discussion. This work was supported by the Deutsche Forschungsgemeinschaft, grant number KU 1320/5-1 to MK and grant number WO 991/4-1 to WO.

Author information

Authors and Affiliations

  1. Department of Dermatology, Venereology and Allergology, University of Leipzig, Leipzig, Germany

    A Bhattacharya, M Schönherr, Y Raatz & M Kunz

  2. Department of Systems Biology and Bioinformatics, University of Rostock, Rostock, Germany

    U Schmitz & O Wolkenhauer

Authors
  1. A Bhattacharya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. U Schmitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. O Wolkenhauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M Schönherr
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Y Raatz
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M Kunz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A Bhattacharya.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Oncogene website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bhattacharya, A., Schmitz, U., Wolkenhauer, O. et al. Regulation of cell cycle checkpoint kinase WEE1 by miR-195 in malignant melanoma. Oncogene 32, 3175–3183 (2013). https://doi.org/10.1038/onc.2012.324

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2012.324

Keywords

This article is cited by

Search

Advanced search

Quick links